Colchicine, a widely available gout medication, has received FDA approval to be used in low dose to prevent cardiovascular events in patients with proven coronary disease.
Jun 29, 2023
0
32
Heart transplant patients are notorious for developing an aggressive form of coronary artery disease that can often result in heart failure, death or the need for repeat transplantation. The condition can also have a negative ...
Jun 18, 2012
0
0
Heart attack patients treated at hospitals with low care scores are at greater risk for another heart attack and/or death due to cardiovascular causes, Rutgers researchers found.
Mar 26, 2019
0
34
When it comes to preventing stroke, millions of Americans with irregular heartbeats face a choice: Take one of the powerful but pricey new pills they see advertised on TV, or a much cheaper 60-year-old drug can be a hassle ...
Nov 6, 2015
0
66
In the months since COVID-19 emerged, medical experts have learned a lot about the threat it poses to people with issues such as high blood pressure, diabetes, obesity or cardiovascular disease.
Aug 10, 2020
0
5
(HealthDay)—Sleep-disordered breathing (SDB) severity is associated with lower functional aerobic capacity (FAC) and increased blood pressure, according to a study published in the June 1 issue of The American Journal of ...
Jul 25, 2013
0
0
Physician-scientists from the University of Alabama at Birmingham and the University of Minnesota have recently collaborated to assess the prevalence of cardiovascular risk factors and key cardiovascular diseases among Asian ...
Jun 5, 2019
0
0
(HealthDay)—For patients with ST-segment elevation myocardial infarction (STEMI), high-sensitivity C-reactive protein (hsCRP) measurements at presentation predict subsequent nonfatal MI and cardiac death; and for patients ...
Jan 19, 2013
0
0
(HealthDay)—Tai chi is effective in managing several hypertension-related risk factors in older adults, according to a study published in the October issue of The American Journal of Cardiology.
Sep 16, 2015
0
108
(HealthDay)—Obese and overweight patients with dyslipidemia or hypertension treated with phentermine and topiramate extended-release (PHEN/TPM ER) for weight loss had significant improvements in cardiovascular disease risk ...
Apr 12, 2013
0
0
